Cargando…
FIB-4 and APRI as Predictive Factors for Short- and Long-Term Survival in Patients with Transjugular Intrahepatic Portosystemic Stent Shunts
(1) Background: Transjugular intrahepatic portosystemic shunt (TIPS) is a standard therapy for portal hypertension. We aimed to explore the association of established baseline scores with TIPS outcomes. (2) Methods: In total, 136 liver cirrhosis patients underwent TIPS insertion, mainly to treat ref...
Autores principales: | Keimburg, Simone Anna, Theysohn, Jens, Buechter, Matthias, Rashidi-Alavijeh, Jassin, Willuweit, Katharina, Schneider, Hannah, Wetter, Axel, Maasoumy, Benjamin, Lange, Christian, Wedemeyer, Heiner, Markova, Antoaneta Angelova |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9138812/ https://www.ncbi.nlm.nih.gov/pubmed/35625755 http://dx.doi.org/10.3390/biomedicines10051018 |
Ejemplares similares
-
Diastolic dysfunction is associated with cardiac decompensation after transjugular intrahepatic portosystemic shunt in patients with liver cirrhosis
por: Schneider, Hannah, et al.
Publicado: (2023) -
The Evolution of Transjugular Intrahepatic Portosystemic Shunt: Tips
por: Fanelli, Fabrizio
Publicado: (2014) -
Transjugular intrahepatic portosystemic shunt in patients with cirrhosis: Indications and posttransjugular intrahepatic portosystemic shunt complications in 2020
por: Horhat, Adelina, et al.
Publicado: (2021) -
Parallel Shunt for the Treatment of Transjugular Intrahepatic Portosystemic Shunt Dysfunction
por: Luo, Xuefeng, et al.
Publicado: (2013) -
Safety and feasibility of transjugular intrahepatic portosystemic shunt in elderly patients with liver cirrhosis and refractory ascites
por: Stockhoff, Lena, et al.
Publicado: (2020)